Non-invasive Aesthetic Treatment Market Report by Procedure (Injectables, Skin Rejuvenation, and Others), Injectables (Botulinum Toxin, Hyaluronic Acid, Calcium Hydroxylapatite, and Poly-L-Lactic Acid), Skin Rejuvenation (Photo Rejuvenation, Chemical peel, Micro Ablative Resurfacing, and Full field Ablative), Others (Hair Removal, and Non Surgical Fat Reduction), Gender (Male, and Female), End User (Hospital/surgery centre, Medspa, Traditional Spa, and HCP Owned Clinic), Country and Company Analysis 2024-2032

Non-Invasive Aesthetic Treatment Market Analysis

Non-Invasive Aesthetic Treatment Market size was valued at US$ 65.65 Billion in 2023. It is projected to increase at a CAGR of 14.43% from 2024 to 2032. Renub Research forecasted the value to be US$ 220.84 Billion by 2032.

A non-invasive approach is a form of treatment that does not require surgery or the removal of tissues. Now a days, people think that aging is a serious matter of appearance. Age spots, sagging skin, and wrinkles around the mouth or eyes are signs of aging. There are many operations these days to turn rewind time. Many non-invasive cosmetic procedures can reduce the effects of aging on facial features. Non-invasive, commonly used cosmetic products include peels, hyaluronic acid, and botulinum toxin. Today, patients choose over-the-counter cosmetics over topical ones because they cost less, have shorter healing times, have no scarring, and are less likely to cause side effects.

Market Trends for Non-Invasive Aesthetic Treatments:

Increasing urge to appear Attractive:

Social media's growing recognition and interconnection have made human beings's physical appearances more and more massive in both social and professional spheres. Through video calls, humans are interacting extra visually and trying to project their pleasant selves. In addition, the standard of beauty is growing because of the media's and popular tradition's emphasis on appearances, as evidenced by the roles played with the aid of celebrities, movies, and style commercials. This encourages people, in particular millennials and Generation Z, to search for non-surgical techniques to correct defects and achieve a favored aesthetic appeal.

o    The ISAPS stated that 18,857,311 non-surgical aesthetic procedures were achieved globally in 2022.
o    Botulinum Toxin turned into the best-performing non-surgery in 2022, with 9,221,419 procedures worldwide.
o    Hyaluronic acid became the second most demanded non-surgical procedure in 2022, which recorded 4,312,037 procedures globally.
o    In 2022, 642,067 non-surgical fat reduction procedures had been performed globally in women, and 136,650 procedures were performed for men.
o    Globally, 916,869 hair removal procedures were executed in 2018 and 1,798,253 in 2022, indicating a 96.1% growth between 2018 and 2022.

Technological Advancement in Non-surgical Procedures:

Technological advancements have made non-invasive aesthetic procedures extra effective and available, drawing in more folks that want to look better without invasive surgical procedure. This fashion will propel the growth of the non-invasive aesthetic treatment market. The introduction of power-primarily based, non-invasive devices that focus on fats and muscle the usage of radiofrequency, ultrasound, mild, and laser is likewise revolutionizing the sector. These imaginitive technology allow sufferers to get hold of treatments without surgery or anesthesia, lowering dangers and rushing up healing.

o    Lumenis Ltd added a unique non-invasive treatment, the NuEra Tight with FocalRF era, in August 2020.
o    The Harmony XL Pro device, brought by using Alma Lasers in 2020, is intended to offer lots of non-invasive beauty remedies, including pimples treatment, hair elimination, and pores and skin rejuvenation. The system, which uses modern IPL technology, is expected to propel the enterprise's enlargement inside the market for non-invasive beauty strategies.

North America Non-Invasive Aesthetic Treatment Market:

The ISAPS-International Society of Aesthetic Plastic Surgery survey states that the US dominates the worldwide marketplace for minimally invasive surgical processes. The marketplace's growth become pushed through the USA populace's increasing acceptance fee of technologically superior healing procedures amongst both old and young. According to the American Society of Plastic Surgeons, the variety of Botox injections given inside the US rose via almost 845 percentage over 18 years, from 2000 to 2018. In addition, the USA' more and more getting old population, excessive stage of disposable income, and developing emphasis on appearances have all helped fuel the growth of North America's non-invasive aesthetic remedy enterprise.

o    As per ISAPS, the United States possessed the top rank in terms of non-surgical procedures carried out worldwide.
o    With 7,461 plastic surgeons, the United States has the highest number of surgeons.
o    Regarding non-surgical treatments, the United States leads the world with 5,802,761 procedures in 2022.

Non-Invasive Aesthetic Treatment Market in Asia Pacific:

Over the projected time, Asia Pacific is expected to be one of the most profitable markets. This is attributed to the massive variety of young individuals and the fast-aging populace in the place. Growing focus on the style of non-invasive aesthetic remedies available, growing living standards, and greater freestanding finances are the main elements anticipated to power market expansion during the forecast period.

The United Nations predicts that by 2050, around 80% of the world's elderly population will reside in low—and middle-income nations. As a result, market participants are seeing profitable growth prospects in the Asia Pacific area.

Non-Invasive Aesthetic Treatment Market Key Players Analysis:

Some major companies are present in the global breast implant industry. These are Johnson & Johnson, Bausch Health Companies Inc., Cutera Inc., AbbVie Inc., Sisram Medical Ltd, Galderma S.A., Sientra Inc., and Revance Therapeutics Inc.

Non-Invasive Aesthetic Treatment Market Key Players News:

Feb 2024: Modern medical aesthetic equipment provider Aesthetic Management Partners (AMP) has launched Plasmage, the first fractional plasma device available. This device offers clinicians precise control over wrinkles, crepey skin, delicate skin on the face and body, and a range of dermatological conditions like fibromas, skin tags, and xanthelasma.

January 2024: The medical aesthetics platform Empower Aesthetics has announced a collaboration with AW Skin Co., a renowned medical spa and wellness center with three locations in Cool Springs, Franklin, and Murfreesboro, Tennessee, and DermaTouch RN, a top medical aesthetic practice with locations in Houston and San Antonio, Texas.

January 2022: Galderma declared that it has finished acquiring ALASTIN Skincare®, Inc. and has acquired antitrust approval from US regulators.

January 2021: Candela announced the introduction of the Frax Pro system. The FDA-approved non-ablative fractional device is the first to resurface dual-depth skin with the groundbreaking Frax 1940 and the advanced Frax 1550 applicators.

January 2021: The AbbVie business Allergan Aesthetics has introduced CoolSculpting Elite, a next-generation fat-reduction device whose applicators accentuate the body's natural contours.

Procedure – Market breakup in 3 viewpoints:

1.    Injectables
2.    Skin Rejuvenation
3.    Others

Injectables – Market breakup in 4 viewpoints:

1.    Botulinum Toxin
2.    Hyaluronic Acid
3.    Calcium Hydroxylapatite
4.    Poly-L-Lactic Acid

Skin Rejuvenation – Market breakup in 4 viewpoints:

1.    Photo Rejuvenation
2.    Chemical peel
3.    Micro Ablative Resurfacing
4.    Full field Ablative

Others – Market breakup in 2 viewpoints:

1.    Hair Removal
2.    Non Surgical Fat Reduction

Gender – Market breakup in 2 viewpoints:

1.    Male
2.    Female

End User – Market breakup in 2 viewpoints:

1.    Hospital/surgery centre
2.    Medspa
3.    Traditional Spa
4.    HCP Owned Clinic

Country – Market breakup of 17 Countries:

1.    United States
2.    Brazil
3.    Mexico
4.    Argentina
5.    Colombia
6.    Germany
7.    United Kingdom
8.    Italy
9.    Spain
10.    Greece
11.    Romania
12.    Turkey
13.    Japan
14.    India
15.    Iran
16.    Thailand
17.    Rest of the World

All the key players have been covered from 4 Viewpoints:

•    Business Overview
•    Product Portfolio
•    Recent Development
•    Revenue Analysis

Key Players Analysis:

1.    Johnson & Johnson
2.    Bausch Health Companies Inc.
3.    Cutera Inc.
4.    AbbVie Inc.
5.    Sisram Medical Ltd.
6.    Galderma S.A
7.    Sientra Inc.
8.    Revance Therapeutics Inc.

Report Details: